Cargando…
Precision medicine in cardiorenal and metabolic diseases with routinely collected clinical data: a novel insight
Autores principales: | Li, Sheyu, Shi, Qingyang, Litvin, Valentyn, Manski, Charles F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579962/ https://www.ncbi.nlm.nih.gov/pubmed/36268465 http://dx.doi.org/10.1093/pcmedi/pbac025 |
Ejemplares similares
-
Cardiorenal Outcomes With Ertugliflozin by Baseline Metformin Use: Post Hoc Analyses of the VERTIS CV Trial
por: Cosentino, Francesco, et al.
Publicado: (2022) -
INOSA Guidelines in the era of precision medicine
por: Chakraborty, Ranajit
Publicado: (2015) -
Biomarkers in Cardiorenal Syndrome and Potential Insights Into Novel Therapeutics
por: Chung, Edmund Y. M., et al.
Publicado: (2022) -
The Effect of Aldosterone on Cardiorenal and Metabolic Systems
por: Otsuka, Hiromasa, et al.
Publicado: (2023) -
Tissue navigator, an important position in the Pathology laboratory in the Precision Medicine era
por: Tavora, F., et al.
Publicado: (2023)